Application of Continuous Quality Improvement in Decreasing Hyperuricemia in Patients with Stage 3-4 Chronic Kidney Diseases

崔文英,徐睿,张东亮,尹道馨,刘文虎
DOI: https://doi.org/10.3969/j.issn.1007-9572.2012.11.003
2012-01-01
Chinese General Practice
Abstract:Objective To explore the role of Continuous Quality Improvement(CQI) in decreasing hyperuricemia in patients with stage 3-4 chronic kidney disease(CKD).Method Totally 98 CKD patients with hyperuricemia were enrolled in this study.PDCA(Plan,Do,Check and Act) methodology was applied to enhance the general management of these patients.Results In the 98 cases of patients,the average blood uric acid was(406.38±94.97)μmol/L before CQI management and(379.10±86.07) μmol/L after 6-month general management(P0.05).Conclusion CQI effectively decreases the blood uric acid level in stage 3-4 CKD patients and therefore lowers the risk of Hyperuricemia.
What problem does this paper attempt to address?